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Psoriasis is a chronic skin disorder affecting approxi-
mately 2% of the Caucasian population. Family
clustering of the disease is well established and non-
parametric linkage analyzes have mapped disease
susceptibility loci on chromosomes 6p (PSORS1)
and 17q (PSORS2). Noncon®rmed evidence for link-
age is also available for chromosomes 2q 3q, 4q
(PSORS3), 8q, 16q, and 20p. We mapped an add-
itional susceptibility locus on chromosome 1q21
(PSORS4). In this study, we have carried out a link-
age disequilibrium analysis, in order to achieve a
®ner localization. We recruited 79 triads from con-
tinental Italy and typed them at ®ve loci spanning
the 1.6 Mb region generating the highest multipoint
LOD scores in our previous linkage study. We
observed signi®cant evidence for association with
D1S2346 marker (p = 0.004). Results consistent with
this data were obtained by typing an independent
sample that included 28 patients and 56 controls,
originating from Sardinia. In fact, p values of 0.02
were observed with both D1S2346 and D1S2715
markers. We sought further con®rmation of our
results by typing both samples with two novel
markers (140J1C and 140J1D) ¯anking D1S2346.
Marker 140J1D generated a p value of 0.003 in the
continental Italy sample where a D1S2346/140J1D
haplotype was found with a higher frequency among
patients' chromosomes. Altogether our data indicate
that the 1q21 susceptibility gene may be localized in
the genomic interval spanned by D1S2346 and
140J1D. This report provides evidence supporting
the re®nement of a non-HLA psoriasis susceptibility
locus. Key words: complex disease/genetic isolate/linkage
disequilibrium. J Invest Dermatol 116:728±730, 2001
P
soriasis (PS, OMIM 177900) is a chronic in¯ammatory
skin disorder affecting approximately 2% of the
Caucasian population (Nevitt and Hutchinson, 1996).
The disease is characterized by the occurrence of skin
lesions showing epidermal hyper-proliferation, abnormal
keratinocyte differentiation, and in®ltration of in¯ammatory
elements (Barker, 1991). Familial clustering of PS is well established
(Hellgren, 1967) and twin studies indicate that heritability is in the
range of 70%±90% (Faber and Nall, 1974). Parametric and
nonparametric linkage analysis have mapped PS susceptibility loci
to chromosomes 2q, 3q, 4q, 6p, 8q, 16q, 17q, 19p, and 20p (Capon
et al, 2000; Lee et al, 2000); however, replication of linkage has
been obtained only for chromosomes 6p21 (PSORS1) and 17q
(PSORS2) (Nair et al, 1997; Jenisch et al, 1998; Leder et al, 1998;
Enlund et al, 1999; Lee et al, 2000). We have assigned an additional
susceptibility locus to chromosome 1q21 (PSORS4) (Capon et al,
1999), which was also con®rmed in an independent genome scan
(Bhalerao and Bowcock, 1998). The PSORS4 susceptibility locus
lies within the region of the Epidermal Differentiation Complex
(OMIM #601588), a cluster of at least 25 genes involved in the
terminal differentiation of human epidermis (Mischke et al, 1996).
In particular, our previous linkage study positioned PSORS4 in
the 1.6 Mb region between D1S1664 and D1S305 markers, on the
basis of multipoint LOD score analysis (Capon et al, 1999). In this
study, we adopted a linkage disequilibrium (LD) mapping
approach, in order to con®rm and further re®ne the location of
the susceptibility region. LD mapping is achieved by testing for
different frequencies of a marker allele in samples of normal and
disease chromosomes. Association can arise if the marker itself is
causally implicated in the disease or is in linkage disequilibrium
with a susceptibility locus (Jorde, 1995). In this study we
demonstrated a signi®cant association between PS and markers
D1S2346 and 140J1D, in the Italian population. Moreover, we
detected an association with markers D1S2346 and D1S2715, in
the genetic isolate of Sardinia.
MATERIALS AND METHODS
Patient ascertainment A total of 79 genetically independent triads
originating from continental Italy (i.e., all Italian regions except Sardinia)
were recruited from the Dermatology Departments of the IDI Institute,
the Catholic University and ``Tor Vergata'' University of Rome. Both
parents were available for all triads and in 57 of 79 cases one of them
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was affected too. Thus, the continental Italy cohort included 237
subjects, 136 of which were affected. An additional sample including 28
affected subjects and 56 unrelated healthy controls originating from the
province of Sassari, in north-western Sardinia, was collected at the
University of Cagliari. In all cases, consensus diagnosis of the disease was
assessed by two expert dermatologists who examined skin, nails, and
joints of all patients and their parents. Individuals were considered
affected if they had plaque PS and any doubtful cases were excluded. All
subjects granted their informed consent for participating to this study.
Microsatellite genotyping Genomic DNA was extracted from
peripheral blood lymphocytes by standard phenol-chloroform extraction.
Genotyping was performed at seven loci: D1S1664, 140J1D, D1S2346,
140J1C, D1S2715, D1S303, and D1S305. Known markers were selected
from the CHLC (D1S1664) and the CEPH-Genethon (D1S2346,
D1S2715, D1S303, D1S305) maps, available, respectively, at http://
www.chlc.org and http://www.genethon.fr web sites. Microsatellites
140J1C and 140J1D were identi®ed by screening the draft sequence of
PAC 140J1 (Genebank acc. n. AL161636) for CA repeats. Intermarker
distances reported in Fig 1 were derived from published physical maps
of the 1q21 region (Maestrini et al, 1996; Marenholz et al, 1996;
Shackleton et al, 2000). The exact position of 140J1C and 140J1D
cannot be determined since PAC 140J1 sequence is at present available
in 19 unordered pieces; however, a BLAST search of the htgs database
(available at http://www/ncbi.nlm.nih.gov) revealed that 140J1D
sequence matches a portion of PAC 19K8, overlapping the proximal end
of PAC 140J1 (Fig 1). On the other hand, 140J1C does not match any
19K8 sequence. Thus, 140J1D lies close to D1S2346 in the region of
overlap between 19K8 and 140J1, whereas 140J1C maps to the distal
portion of 140J1 (Fig 1). Marker heterozygosity ranged from 0.52
(D1S303) to 0.83 (D1S305, D1S2346). PCR were performed on 50 ng
of DNA in a 15 ml reaction mixture containing 1.5 ml of reaction buffer
(100 mM Tris-HCL, pH 8.3, 500 mM KCl), 1.5 ml MgCl2 (25 mM),
1.5 ml dNTP mix (2.5 mM), 5 pmol of 5¢-FAM labeled forward primer,
5 pmol of reverse primer, and 0.6 U of AmpliTaq Gold (Perkin-Elmer
Applied Biosystems, Foster City, CA). Primers J1C-f (5¢-AGAGCA-
CCCTATCTGGATGCC-3¢), J1C-r (5¢-TTTGATGATCTAACAT-
GCC-3¢), J1D-f (5¢-AACAGCACAGAACCCACAGG-3¢), and J1D-r
(5¢-AACCCTATAGACTTCCGTCC-3¢) were used to amplify 140J1C
and 140J1D markers. All microsatellites were ampli®ed at an annealing
temperature of 55°C, with the exception of 140J1C (50°C) and 140J1D
(52°C). Pooled PCR products were run for 18 min on an ABI 310
automated sequencer (Perkin-Elmer Applied Biosystems), in the presence
of TAMRA GS-500 ¯uorescent size marker (Perkin-Elmer Applied
Biosystems). GENESCAN 3.1 and GENOTYPER 2.0 softwares
(Perkin-Elmer Applied Biosystems) were used for data collection and
allele sizing.
Statistical analysis To test the null hypothesis of no association, the
frequency distribution of alleles on disease-bearing and control
chromosomes was analyzed in the Italian and Sardinian samples, using
the c2 test. When examining the Italian cohort, nontransmitted parental
alleles were used as a control sample, in order to avoid the confounding
effect of population strati®cation. When none of the parents was
affected, both parental transmitted alleles were counted as disease-
bearing. In those trios where one parent was affected, the allele that he/
she transmitted to the affected offspring was counted as disease-bearing.
In fact most of these trios had been sampled from larger three-generation
pedigrees where PS segregation was consistent with an autsomal
dominant transmission. Statistical analyzes were also repeated using a
standard TDT (i.e., counting as transmitted the alleles inherited from
both parents, regardless of their affection status). The c2 test was carried
out using the combined allele method, that is a modi®cation of the tests
originally designed for di-allelic markers (Votruba et al, 1998). Brie¯y, an
allele is selected that is believed to be associated with the disease (e.g.,
the most frequent allele found on disease chromosomes) and the others
are merged together, thus reducing the locus to a di-allelic system. Some
information is lost using this method, since it reduces multiallelic markers
to bi-allelic systems; however, the test has the advantage of generating
homogeneous c2 values (there is always 1 df) that can be compared
directly between one another (Votruba et al, 1998). Disease-bearing and
control haplotypes were inferred from the genotypes of the affected
probands and those of their parents.
RESULTS
The signi®cance of the p values generated by the various markers is
reported in Fig 1. In the Italian cohort, the 101 bp allele of
D1S2346 marker showed a signi®cant association with the disease
(c2 = 8.17 and p = 0.004). Statistical signi®cance was con®rmed
when a standard TDT was performed (the allele was found in
12.2% transmitted vs. 5.1% not transmitted chromosomes, p
= 0.043). Because the TDT has a scarce power to detect association
with low frequency alleles, we sought a further con®rmation of our
results by testing the hypothesis of a skewed transmission of the 101
allele. We observed that the allele was transmitted to affected
offspring in 19 of 27 meioses and obtained a p value of 0.006
(c2 = 7.41), consistent with our association ®ndings. The other
known microsatellites that we examined failed to generate
signi®cant p values in the Italian sample. In order to con®rm the
involvement of the interval surrounding D1S2346 in disease
susceptibility, we typed both this marker and two ¯anking loci
(D1S1664, D1S2715) in a sample from an independent population,
i.e., the genetic isolate of Sardinia. Using the combined allele
variant of the c2 test, D1S2346 and D1S2715 generated p values of
0.026 (c2 = 4.95) and 0.024 (c2 = 5.07), respectively. Because
D1S2346 showed association with PS in both our samples, we
sought a further con®rmation of our results by typing additional
microsatellites lying in the proximity of this marker. We screened
for CA repeats the draft sequence of PAC 140J1, which contains
D1S2346. We identi®ed four repeats, apart from D1S2346. After
typing a subset of our trios, we selected the two markers displaying
the highest heterozygosity, i.e., 140J1C (het: 0.69) and 140J1D
(het: 0.71). We typed these markers in both our samples. We failed
to detect any association in the Sardinian data set. In the continental
Italy sample, however, allele 106 of marker 140J1D showed
signi®cant association (c2 = 8.94; p = 0.003). Again, association
®ndings were consistent with standard TDT results (the 106 allele
was found in 52.6% transmitted vs. 40.8% not transmitted
chromosomes, p = 0.045), and with the observation of skewed
allele transmission (the allele was transmitted to affected offspring in
36 of 56 informative meioses; c2 = 8.04, p = 0.004). As expected,
the D1S2346±101 140J1D-106 haplotype was found with in-
creased frequency among disease chromosomes compared with
control chromosomes (6.9% vs. 1.9%).
DISCUSSION
Traditionally, LD has been a powerful tool for the identi®cation of
rare disease alleles; however, in recent years LD mapping has also
become a popular method for the study of susceptibility loci
predisposing to common diseases. In particular, LD mapping is the
tool of choice for re®ning the genetic location of susceptibility loci
assigned to broad chromosome regions by linkage analysis
(Terwilliger and Weiss, 1998). In the study of PS susceptibility,
Figure 1. Summary of the association data generated by the
Italian population. Distances between known microsatellites are plotted
on the x-axis, together with the position of PACs 19K8 and 140J1. At
present, the postion of marker 140J1D with respect to D1S2346 cannot
be determined, thus the location of this marker represented in the ®gure
is an arbitrary one. Such incertitude, however, does not in¯uence the
interpretation of our ®ndings.
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this approach has been successfully applied to the re®nement of the
PSORS1 susceptibility locus, lying within the HLA region
(Balendran et al, 1999; Oka et al, 1999; Nair et al, 2000). Here,
we report the ®rst attempt at narrowing a non-HLA PS suscep-
tibility locus. We typed a cohort of 79 Italian triads at seven
markers spanning the 1.6 Mb region identi®ed in our previous
linkage study. This analysis demonstrated a signi®cant association
with the 101 allele of D1S2346 and the 106 allele of 140J1D.
Moreover, when phases were assigned, the D1S2346±101 140J1D-
106 haplotype was found with increased frequency among disease
chromosomes. It is interesting to note that this haplotype segregates
in the PS31 family where linkage to the 1q21 region was originally
demonstrated (Capon et al, 1999).
Several methodologic papers have proposed the use of multiple
populations to analyze risk alleles identi®ed in a given ethnic group,
thus comparing their effects in samples exposed to other sources of
genetic and environmental variation (Merriman et al, 1997; Valdes
et al, 1997). In this context, we have extended the analysis of
D1S2346 and two ¯anking markers (D1S2715, D1S1664) to a small
sample of Sardinian patients and controls. In fact the population
inhabiting the island of Sardinia is markedly differentiated from the
rest of Italians, as a result of founder effect and geographical
isolation (Cavalli-Sforza et al, 1994). These features make
Sardinians a population of choice for the ®ne mapping of complex
traits, as in recent genetic isolates LD is usually dissipated at a slower
pace and allelic heterogeneity may have been diminished by drift
before demographic expansion took place (Wright et al, 1999).
However small, our Sardinian sample generated p values of 0.02,
corresponding to allele 83 of D1S2346 and allele 149 of D1S2715
marker. As expected for a genetic isolate, LD seems to be
maintained over a longer distance in the Sardinian sample, as it
extends to include D1S2715. The fact that neither 140J1C nor
140J1D show association with PS in this sample may be due to
several factors. These include the lower heterozygosity of markers
in the examined population and the scarce power of the c2 test to
detect association with rare alleles, when small samples are analyzed.
Altogether our results further con®rm our assignment of the
PSORS4 susceptibility locus and suggest that the 1q21 region may
be implicated in PS pathogenesis in the Sardinian population too.
Moreover, LD results in the continental Italy sample point to the
involvement of the D1S2346±140J1D interval, on the region of
overlap between PACs 19K8 and 140J1 (Fig 1). The two
additional markers that we identi®ed on PAC 140J1 (140J1A,
140J1B) do not match 19K8 sequences, and thus do not map to the
region of overlap between the two PACs. Therefore, these markers
are unlikely to show disequilibrium with PS. The D1S2346±
140J1D interval spans about 50 kb on the distal portion of the EDC
(South et al, 1999) and harbors several transcripts. In particular, this
region contains the gene encoding loricrin, a keratinocyte structural
protein, as well as several ESTs (South et al, 1999). Moreover, three
genes coding for in¯ammatory proteins (S100A7, S100A8, and
S100A9) that show a coordinate over-expression in skin lesions of
psoriatic patients (Hardas et al, 1996), map in the proximity of
PAC140J1 (South et al, 1999). It has been hypothesized that a locus
control region (LCR) is responsible for the simultaneous regulation
of these clustered genes (Zhao and Elder, 1997). In this context it is
attractive to speculate that such LCR may reside within the
D1S2346±140J1 interval, and that its alteration may be the
molecular defect underlying the PSORS4 susceptibility locus.
Thus, the functional characterization of this critical region is
expected to provide essential clues for the understanding of PS
susceptibility molecular basis.
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